Showing 701 - 720 results of 100,352 for search '(( i et decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.58s Refine Results
  1. 701
  2. 702
  3. 703
  4. 704

    SUPPORTING INFORMATION. Magaña-Avila et al. PLOS ONE 2024 by MARIA CASTANEDA-BUENO (10104388)

    Published 2024
    “…In transgenic mice sensitive to lethal SARS-CoV-2, however, a significant decrease in gamma ENaC expression was not observed by immunostaining of lungs infected as shown by SARS-CoV2 nucleoprotein staining.…”
  5. 705
  6. 706
  7. 707
  8. 708

    Data from: Colony losses of stingless bees increase in agricultural areas, but decrease in forested areas by Malena Sibaja Leyton (18400983)

    Published 2025
    “…</p><p><br></p><p dir="ltr">The data are related to the scientific paper “Sibaja Leyton M. et al., (under review) Colony losses of stingless bees increase in agricultural areas, but decrease in forested areas”.…”
  9. 709
  10. 710

    Scara5 expression decreased during retinopathy. by Luísa Mendes-Jorge (635136)

    Published 2014
    “…C: The immunolabeling of paraffin-embedded retinal sections with anti-Scara5 antibody confirmed that Scara5 expression decreased throughout the parenchyma. …”
  11. 711
  12. 712

    Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

    Published 2024
    “…<p>Immunofluorescent staining of guinea pig brain tissue for DAPI (blue) and claudin V (cyan) in vessels was performed. Representative images of the frontal cortex (A–D), cerebral nuclei (F–I), brain stem (K–N), thalamus (P–S), and hippocampus (U–X) 15 days post-infection are shown. …”
  13. 713
  14. 714
  15. 715
  16. 716
  17. 717
  18. 718
  19. 719
  20. 720

    Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing by Martin M. J. Kirschner (727302)

    Published 2015
    “…One patient with lymphoid BC/Ph+ ALL who harbored a T315I ABL mutation and was treated with ponatinib was found to have developed a newly acquired V216M TP53 mutation (12% of transcripts) when becoming resistant to ponatinib. …”